8-K: Marpai Reports Fourth Quarter and Full Year 2024 Financial Results, Shows Strong Financial Improvement

Marpai, Inc. announced its Q4 and full year 2024 financial results, highlighting a decrease in net revenues but significant improvements in operating expenses and net losses.

Summary

• Marpai, Inc., a technology platform company operating as a Third-Party Administrator (TPA), announced its financial results for the fourth quarter and fiscal year 2024.
• Net revenues for Q4 2024 were $6.6 million, a 6.0% decrease compared to Q3 2024.
• Operating expenses for Q4 2024 were $5.3 million, a 5.1% increase compared to Q3 2024.
• The operating loss for Q4 2024 was $2.7 million, a 12.2% improvement compared to Q3 2024.
• Net loss for Q4 2024 was $1.2 million, a 67.5% improvement year-over-year.
• Basic and diluted earnings per share in Q4 2024 were ($0.08), an improvement of $0.22 per share compared to Q3 2024.
• Net revenues for the full year 2024 were $28.2 million, a 24.2% decrease year-over-year.
• Operating expenses for the full year 2024 were $31.2 million, a 23.7% improvement year-over-year.
• The operating loss for the full year 2024 was $22.1 million, a 21.1% improvement from the prior year.
• Net loss for the full year 2024 was $22.1 million, a 23.2% improvement year-over-year.
• Basic and diluted earnings per share for the full year 2024 were ($1.92), an improvement of $2.22 per share year-over-year.
• Adjusted EBITDA for the year ended December 31, 2024, amounted to a loss of $9.1 million, compared to a loss of $20.2 million for the year ended December 31, 2023.
• The company expects to hold a webcast to discuss the results on March 27, 2025.

Sentiment

Score: 7

Explanation: The sentiment is cautiously optimistic. While revenue is down, the company has made significant strides in reducing losses and improving efficiency. The forward-looking statements about future profitability contribute to the positive outlook.

Positives

• Marpai significantly reduced its net loss in Q4 2024 by 67.5% year-over-year, reaching $1.2 million.
• Operating expenses for the full year 2024 decreased by 23.7% year-over-year, totaling $31.2 million.
• The adjusted EBITDA loss improved from $20.2 million in 2023 to $9.1 million in 2024, indicating better resource utilization and expense reduction.
• Basic and diluted earnings per share improved by $2.22 year over year.

Negatives

• Net revenues decreased by 6.0% in Q4 2024 compared to Q3 2024, reaching $6.6 million.
• Net revenues for the full year 2024 decreased by 24.2% year-over-year, totaling $28.2 million.
• Operating expenses increased by 5.1% in Q4 2024 compared to Q3 2024, totaling $5.3 million.

Risks

• The company acknowledges risks related to general economic and market conditions, competitive factors, customer acceptance of new products, and managing business growth.
• The company's forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from expectations.

Future Outlook

Marpai plans to introduce high-impact PBM-based products in the second half of 2025 and believes these actions will fuel revenue growth and position the company for profitability in 2025.

Management Comments

• Damien Lamendola, CEO, stated that Marpai's team engineered an exceptional turnaround, dramatically reducing losses.
• The CEO also mentioned that the company is propelling towards growth and profitability by streamlining costs and deploying innovative services.

Industry Context

Marpai operates in the $22 billion TPA sector, serving self-funded employer health plans, and aims to transform the market by offering affordable, intelligent healthcare solutions.

Comparison to Industry Standards

• The document does not provide specific comparisons to industry standards or competitors.
• The document mentions that Marpai competes in the $22 billion TPA sector, but does not provide details on the performance of other companies in the sector.

Stakeholder Impact

• Shareholders may be encouraged by the reduced losses and improved efficiency.
• Employees may be affected by the company's efforts to streamline costs.
• Customers (self-funded employer health plans) may benefit from the company's focus on affordable, intelligent healthcare solutions.

Next Steps

• Marpai expects to host a conference call and webcast on March 27, 2025, to discuss the financial results.
• The company plans to introduce high-impact PBM-based products in the second half of 2025.

Key Dates

Keywords

financial results, TPA, healthcare, EBITDA, net loss, net revenue, Marpai